DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/v6m7z7/china_hospital) has announced the addition of the "China Hospital Industry Report, 2015-2018" report to their offering.
Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decline whereas private hospitals increased rapidly.
During the period from 2011 to late May 2015, the number of private hospitals in China advanced 4,713, with the share up from 38.4% to 49.7%. But in point of revenue, China's private hospitals just accounted for 10%.
In terms of medical service, between January and May 2015, China saw 1.2152 billion hospital visits, up 5.4% from a year earlier. Although the number of public hospitals occupied only 50.3% of total hospitals, yet the public hospital visits represented up to 89.1%, which was mainly due to the fact that private hospitals are small in scale and have relatively poor treatment level and lower public awareness.
At present, more investment has gone to specialized hospitals, which have captured long-term attention from social capital, hence a great market demand. As of the end of 2014, the number of specialized hospitals in China were expected to reach 5,449, making up 21.4% of the total. Among them, mental hospitals, maternity hospitals, orthopaedic hospitals, stomatological hospitals, and ophthalmic hospitals constitute the mainstay. Tumor hospitals generated the most revenue while beauty hospitals, ophthalmic hospitals, and stomatological hospitals produced relatively higher profit margin.
In recent years, the State has introduced a series of favorable policies designed to encourage private capital into the hospital industry, thus setting off a wave of social capital inrush to medical service. Currently, many private companies including Aier Eye Hospital Group, TC Medical, Mayinglong Pharm, Shanghai Fosun Pharmaceutical (Group), Jinling Pharmaceutical Company Limited, and Phoenix Healthcare Group have ventured into the field of medical service. Among them, Aier Eye Hospital Group and Shanghai Fosun Pharmaceutical (Group) achieved good results in business development. In H1 2015, the medical service revenue for the two companies totaled RMB1.175 billion and RMB674.4 million, respectively.
Key Topics Covered:
1. Overview of China Hospital Industry
2. Development of China Hospital Industry
3. Development of Specialized Hospitals in China
4. Development Forecast of China Hospital Industry
5. Investment in China Hospital Industry
6. Major Private Hospitals in China
- Aier Eye Hospital Group
- China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
- Concord Medical Services Holdings Limited
- Guizhou Yibai Pharmaceutical
- Inner Mongolia Furui Medical Science
- Jinling Pharmaceutical Company Limited
- Kangmei Pharmaceutical
- Mayinglong Pharm
- Parkway Pantai
- Phoenix Healthcare Group
- Shanghai Fosun Pharmaceutical (Group)
- Shinva Medical
- TC Medical
- Wuhan Jianmin Pharmaceutical Groups Corp.
- Xi'an International Medical Investment Co., Ltd.
For more information visit http://www.researchandmarkets.com/research/v6m7z7/china_hospital